Advanced Gastrointestinal Stromal Tumor clinical trials

Explore recruiting advanced gastrointestinal stromal tumor clinical trials.

Recruiting advanced gastrointestinal stromal tumor studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Gastrointestinal Stromal Tumor trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study to learn the effects of ripretinib (study drug) on how midazolam behaves in the body of people with advanced gastrointestinal stromal tumor

Netherlands, Spain, Italy

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Master Protocol for the Multi-Cohort, Phase 1/2 Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies

Portugal, Netherlands, Denmark, Spain, Italy, Germany +2 more

Phase I and Phase II (Integrated)- Other EU CTIS Study details

An International, Phase 3, Randomized, Multicenter, Open-label Study of Ripretinib vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumor (GIST) with KIT Exon 11 and Co-occurring KIT Exons 17 and/or 18 Mutations Who Were Previously Treated with Imatinib (INSIGHT)

Norway, France, Germany, Netherlands, Spain, Poland +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

ATEZOGIST – A prospective, randomized, multicenter, comparative study of the efficacy of imatinib resumption combined with atezolizumab versus imatinib resumption alone in patients with unresectable advanced gastrointestinal stromal tumors (GIST) after failure of standard treatments

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Open-label, Phase 3 Extension Study to Evaluate the Long‑term Efficacy and Safety in Participants Who Are Currently on Treatment in a Belzutifan Study (LITESPARK-043)

Czechia, Spain, Poland, Belgium, Finland, Germany +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Advanced Gastrointestinal Stromal Tumor trials by city

Advanced Gastrointestinal Stromal Tumor clinical trials

Recruiting advanced gastrointestinal stromal tumor studies right now

A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments

Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten)

Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

Agnostic Therapy in Rare Solid Tumors

PH 2 Pemigatinib in SDH-deficient GIST

The Efficacy and Safety of Temozolomide in SDH-deficient GIST

Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)